Normative values for esophageal functional lumen imaging probe measurements: A meta‐analysis
Background The functional lumen imaging probe (Endoflip™) is increasingly used for evaluation of patients with esophageal symptoms. To improve the interpretation of Endoflip™ in clinical practice, normative values with appropriate cut‐off values are required. Methods Original clinical studies descri...
Saved in:
Published in | Neurogastroenterology and motility Vol. 34; no. 11; pp. e14419 - n/a |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
England
Wiley Subscription Services, Inc
01.11.2022
John Wiley and Sons Inc |
Subjects | |
Online Access | Get full text |
ISSN | 1350-1925 1365-2982 1365-2982 |
DOI | 10.1111/nmo.14419 |
Cover
Abstract | Background
The functional lumen imaging probe (Endoflip™) is increasingly used for evaluation of patients with esophageal symptoms. To improve the interpretation of Endoflip™ in clinical practice, normative values with appropriate cut‐off values are required.
Methods
Original clinical studies describing Endoflip™ use for measurements of esophageal motility in healthy adults were considered. Meta‐analysis was performed based on published values.
Results
A total of 17 articles were included in the systematic review, 15 of which were included in the meta‐analysis, representing 154 unique subjects. At 40 ml distention, the 5th–95th and 10th–90th percentiles for esophagogastric junction distensibility index (EGJ‐DI) were 1.96–10.95 mm2/mmHg and 2.36–8.95 mm2/mmHg, respectively. An EGJ‐DI below 2 mm2/mmHg was found in 5.4%, and below 3 mm2/mmHg in 20.1% of healthy subjects. At 50 ml distention, the 5th–95th and 10th–90th percentiles for EGJ‐DI are 2.86–10.66 mm2/mmHg and 3.28–9.12 mm2/mmHg, respectively (below 2 mm2/mmHg: 0.6%, 3 mm2/mmHg: 6.3%). The 5th–95th and 10th–90th percentiles for EGJ‐DI at 60 ml distention were 3.06–8.14 mm2/mmHg and 3.33–7.18 mm2/mmHg, respectively (below 2 mm2/mmHg: 0.0%, 3 mm2/mmHg: 7%). A clear cut‐off for lower values was identified while a large spread in values was observed for upper limits of normal for EGJ‐DI for all filling volumes.
Conclusions
Given these observations, we recommend using a cut‐off of 2 mm2/mmHg for clinical practice, values below can be considered abnormal. Given that 5.4% of the healthy subjects will have an EGJ‐DI below 2 mm2/mmHg at 40 ml, we recommend using the 50 and 60 ml distention volumes. The clinical use of an upper limit for normality of EGJ‐DI seems questionable.
A meta‐analysis of clinical studies describing Endoflip™ use for measurements of esophagogastric junction distensibility index (EGJ‐DI) in healthy subjects reveals that only 5.4% of subjects have an EGJ‐DI of 2 mm2/mmHg or lower, values below it can be considered abnormal. The clinical use of an upper limit for normality of EGJ‐DI seems questionable. |
---|---|
AbstractList | The functional lumen imaging probe (Endoflip™) is increasingly used for evaluation of patients with esophageal symptoms. To improve the interpretation of Endoflip™ in clinical practice, normative values with appropriate cut-off values are required.BACKGROUNDThe functional lumen imaging probe (Endoflip™) is increasingly used for evaluation of patients with esophageal symptoms. To improve the interpretation of Endoflip™ in clinical practice, normative values with appropriate cut-off values are required.Original clinical studies describing Endoflip™ use for measurements of esophageal motility in healthy adults were considered. Meta-analysis was performed based on published values.METHODSOriginal clinical studies describing Endoflip™ use for measurements of esophageal motility in healthy adults were considered. Meta-analysis was performed based on published values.A total of 17 articles were included in the systematic review, 15 of which were included in the meta-analysis, representing 154 unique subjects. At 40 ml distention, the 5th-95th and 10th-90th percentiles for esophagogastric junction distensibility index (EGJ-DI) were 1.96-10.95 mm2 /mmHg and 2.36-8.95 mm2 /mmHg, respectively. An EGJ-DI below 2 mm2 /mmHg was found in 5.4%, and below 3 mm2 /mmHg in 20.1% of healthy subjects. At 50 ml distention, the 5th-95th and 10th-90th percentiles for EGJ-DI are 2.86-10.66 mm2 /mmHg and 3.28-9.12 mm2 /mmHg, respectively (below 2 mm2 /mmHg: 0.6%, 3 mm2 /mmHg: 6.3%). The 5th-95th and 10th-90th percentiles for EGJ-DI at 60 ml distention were 3.06-8.14 mm2 /mmHg and 3.33-7.18 mm2 /mmHg, respectively (below 2 mm2 /mmHg: 0.0%, 3 mm2 /mmHg: 7%). A clear cut-off for lower values was identified while a large spread in values was observed for upper limits of normal for EGJ-DI for all filling volumes.RESULTSA total of 17 articles were included in the systematic review, 15 of which were included in the meta-analysis, representing 154 unique subjects. At 40 ml distention, the 5th-95th and 10th-90th percentiles for esophagogastric junction distensibility index (EGJ-DI) were 1.96-10.95 mm2 /mmHg and 2.36-8.95 mm2 /mmHg, respectively. An EGJ-DI below 2 mm2 /mmHg was found in 5.4%, and below 3 mm2 /mmHg in 20.1% of healthy subjects. At 50 ml distention, the 5th-95th and 10th-90th percentiles for EGJ-DI are 2.86-10.66 mm2 /mmHg and 3.28-9.12 mm2 /mmHg, respectively (below 2 mm2 /mmHg: 0.6%, 3 mm2 /mmHg: 6.3%). The 5th-95th and 10th-90th percentiles for EGJ-DI at 60 ml distention were 3.06-8.14 mm2 /mmHg and 3.33-7.18 mm2 /mmHg, respectively (below 2 mm2 /mmHg: 0.0%, 3 mm2 /mmHg: 7%). A clear cut-off for lower values was identified while a large spread in values was observed for upper limits of normal for EGJ-DI for all filling volumes.Given these observations, we recommend using a cut-off of 2 mm2 /mmHg for clinical practice, values below can be considered abnormal. Given that 5.4% of the healthy subjects will have an EGJ-DI below 2 mm2 /mmHg at 40 ml, we recommend using the 50 and 60 ml distention volumes. The clinical use of an upper limit for normality of EGJ-DI seems questionable.CONCLUSIONSGiven these observations, we recommend using a cut-off of 2 mm2 /mmHg for clinical practice, values below can be considered abnormal. Given that 5.4% of the healthy subjects will have an EGJ-DI below 2 mm2 /mmHg at 40 ml, we recommend using the 50 and 60 ml distention volumes. The clinical use of an upper limit for normality of EGJ-DI seems questionable. The functional lumen imaging probe (Endoflip™) is increasingly used for evaluation of patients with esophageal symptoms. To improve the interpretation of Endoflip™ in clinical practice, normative values with appropriate cut-off values are required. Original clinical studies describing Endoflip™ use for measurements of esophageal motility in healthy adults were considered. Meta-analysis was performed based on published values. A total of 17 articles were included in the systematic review, 15 of which were included in the meta-analysis, representing 154 unique subjects. At 40 ml distention, the 5th-95th and 10th-90th percentiles for esophagogastric junction distensibility index (EGJ-DI) were 1.96-10.95 mm /mmHg and 2.36-8.95 mm /mmHg, respectively. An EGJ-DI below 2 mm /mmHg was found in 5.4%, and below 3 mm /mmHg in 20.1% of healthy subjects. At 50 ml distention, the 5th-95th and 10th-90th percentiles for EGJ-DI are 2.86-10.66 mm /mmHg and 3.28-9.12 mm /mmHg, respectively (below 2 mm /mmHg: 0.6%, 3 mm /mmHg: 6.3%). The 5th-95th and 10th-90th percentiles for EGJ-DI at 60 ml distention were 3.06-8.14 mm /mmHg and 3.33-7.18 mm /mmHg, respectively (below 2 mm /mmHg: 0.0%, 3 mm /mmHg: 7%). A clear cut-off for lower values was identified while a large spread in values was observed for upper limits of normal for EGJ-DI for all filling volumes. Given these observations, we recommend using a cut-off of 2 mm /mmHg for clinical practice, values below can be considered abnormal. Given that 5.4% of the healthy subjects will have an EGJ-DI below 2 mm /mmHg at 40 ml, we recommend using the 50 and 60 ml distention volumes. The clinical use of an upper limit for normality of EGJ-DI seems questionable. BackgroundThe functional lumen imaging probe (Endoflip™) is increasingly used for evaluation of patients with esophageal symptoms. To improve the interpretation of Endoflip™ in clinical practice, normative values with appropriate cut‐off values are required.MethodsOriginal clinical studies describing Endoflip™ use for measurements of esophageal motility in healthy adults were considered. Meta‐analysis was performed based on published values.ResultsA total of 17 articles were included in the systematic review, 15 of which were included in the meta‐analysis, representing 154 unique subjects. At 40 ml distention, the 5th–95th and 10th–90th percentiles for esophagogastric junction distensibility index (EGJ‐DI) were 1.96–10.95 mm2/mmHg and 2.36–8.95 mm2/mmHg, respectively. An EGJ‐DI below 2 mm2/mmHg was found in 5.4%, and below 3 mm2/mmHg in 20.1% of healthy subjects. At 50 ml distention, the 5th–95th and 10th–90th percentiles for EGJ‐DI are 2.86–10.66 mm2/mmHg and 3.28–9.12 mm2/mmHg, respectively (below 2 mm2/mmHg: 0.6%, 3 mm2/mmHg: 6.3%). The 5th–95th and 10th–90th percentiles for EGJ‐DI at 60 ml distention were 3.06–8.14 mm2/mmHg and 3.33–7.18 mm2/mmHg, respectively (below 2 mm2/mmHg: 0.0%, 3 mm2/mmHg: 7%). A clear cut‐off for lower values was identified while a large spread in values was observed for upper limits of normal for EGJ‐DI for all filling volumes.ConclusionsGiven these observations, we recommend using a cut‐off of 2 mm2/mmHg for clinical practice, values below can be considered abnormal. Given that 5.4% of the healthy subjects will have an EGJ‐DI below 2 mm2/mmHg at 40 ml, we recommend using the 50 and 60 ml distention volumes. The clinical use of an upper limit for normality of EGJ‐DI seems questionable. A meta‐analysis of clinical studies describing Endoflip™ use for measurements of esophagogastric junction distensibility index (EGJ‐DI) in healthy subjects reveals that only 5.4% of subjects have an EGJ‐DI of 2 mm 2 /mmHg or lower, values below it can be considered abnormal. The clinical use of an upper limit for normality of EGJ‐DI seems questionable. Background The functional lumen imaging probe (Endoflip™) is increasingly used for evaluation of patients with esophageal symptoms. To improve the interpretation of Endoflip™ in clinical practice, normative values with appropriate cut‐off values are required. Methods Original clinical studies describing Endoflip™ use for measurements of esophageal motility in healthy adults were considered. Meta‐analysis was performed based on published values. Results A total of 17 articles were included in the systematic review, 15 of which were included in the meta‐analysis, representing 154 unique subjects. At 40 ml distention, the 5th–95th and 10th–90th percentiles for esophagogastric junction distensibility index (EGJ‐DI) were 1.96–10.95 mm2/mmHg and 2.36–8.95 mm2/mmHg, respectively. An EGJ‐DI below 2 mm2/mmHg was found in 5.4%, and below 3 mm2/mmHg in 20.1% of healthy subjects. At 50 ml distention, the 5th–95th and 10th–90th percentiles for EGJ‐DI are 2.86–10.66 mm2/mmHg and 3.28–9.12 mm2/mmHg, respectively (below 2 mm2/mmHg: 0.6%, 3 mm2/mmHg: 6.3%). The 5th–95th and 10th–90th percentiles for EGJ‐DI at 60 ml distention were 3.06–8.14 mm2/mmHg and 3.33–7.18 mm2/mmHg, respectively (below 2 mm2/mmHg: 0.0%, 3 mm2/mmHg: 7%). A clear cut‐off for lower values was identified while a large spread in values was observed for upper limits of normal for EGJ‐DI for all filling volumes. Conclusions Given these observations, we recommend using a cut‐off of 2 mm2/mmHg for clinical practice, values below can be considered abnormal. Given that 5.4% of the healthy subjects will have an EGJ‐DI below 2 mm2/mmHg at 40 ml, we recommend using the 50 and 60 ml distention volumes. The clinical use of an upper limit for normality of EGJ‐DI seems questionable. A meta‐analysis of clinical studies describing Endoflip™ use for measurements of esophagogastric junction distensibility index (EGJ‐DI) in healthy subjects reveals that only 5.4% of subjects have an EGJ‐DI of 2 mm2/mmHg or lower, values below it can be considered abnormal. The clinical use of an upper limit for normality of EGJ‐DI seems questionable. |
Author | Bredenoord, Albert J. Rancati, Francesca Argov, Mirit Schwartz, Naama Lin, Haiying |
AuthorAffiliation | 1 Department of Gastroenterology and Hepatology Amsterdam UMC Amsterdam The Netherlands 2 Medtronic Minneapolis Minnesota USA |
AuthorAffiliation_xml | – name: 2 Medtronic Minneapolis Minnesota USA – name: 1 Department of Gastroenterology and Hepatology Amsterdam UMC Amsterdam The Netherlands |
Author_xml | – sequence: 1 givenname: Albert J. surname: Bredenoord fullname: Bredenoord, Albert J. email: a.j.bredenoord@amc.nl organization: Amsterdam UMC – sequence: 2 givenname: Francesca surname: Rancati fullname: Rancati, Francesca organization: Medtronic – sequence: 3 givenname: Haiying surname: Lin fullname: Lin, Haiying organization: Medtronic – sequence: 4 givenname: Naama surname: Schwartz fullname: Schwartz, Naama organization: Medtronic – sequence: 5 givenname: Mirit surname: Argov fullname: Argov, Mirit organization: Medtronic |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/35665566$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kc9u1DAQxi1URP_AgRdAkbjAIa3txHbCoVJVQUEq7QWuWE4y3rpy7MVOFu2NR-AZeZLOsm1FK4Fly2PNbz59ntknOyEGIOQlo4cM11EY4yGra9Y-IXuskqLkbcN3NrGgJWu52CX7OV9TSiWv5TOyWwkpBZ498u0iptFMbgXFyvgZcmFjKiDH5ZVZgPGFnUM_uRgw9PMIoXCjWbiwKJYpdlCMYPKcABNTflec4Hsyv3_-Msivs8vPyVNrfIYXt_cB-frh_ZfTj-X55dmn05Pzsq_rqi0r0auuQdeSKQowWGsY9JzRQTAuOzMw07CKK9zUyraqlbC2H1oFg-lo21QH5Hiru5y7EYYe7STj9TKh27TW0Tj9MBPclV7ElW5VI1EXBd7cCqT4Hdsw6dHlHrw3AeKcNZeqprRGGNHXj9DrOCf8MFKK14IKpRhSr_52dG_lrvUIvN0CfYo5J7D3CKN6M1aNY9V_xors0SO2d5PZjAU_4_z_Kn44D-t_S-uLz5fbihsCLrXl |
CitedBy_id | crossref_primary_10_1007_s11695_023_06959_8 crossref_primary_10_1055_a_2333_5232 crossref_primary_10_32725_jab_2024_026 crossref_primary_10_1007_s10353_022_00789_1 crossref_primary_10_1053_j_gastro_2025_01_234 crossref_primary_10_14309_ajg_0000000000002077 crossref_primary_10_3390_ph17121588 crossref_primary_10_1016_j_tige_2023_12_007 crossref_primary_10_1111_apt_17900 crossref_primary_10_5409_wjcp_v12_i4_162 crossref_primary_10_7759_cureus_41504 crossref_primary_10_1111_den_14832 |
Cites_doi | 10.1111/nmo.12651 10.14309/ajg.0000000000000773 10.1007/s00535-013-0876-0 10.1111/nmo.12888 10.1111/nmo.13980 10.1053/j.gastro.2015.08.005 10.2307/3001666 10.1007/s00464-012-2484-0 10.1055/s-0028-1103451 10.1053/j.gastro.2012.04.048 10.1371/journal.pmed.1000097 10.1111/nmo.14058 10.1111/nmo.12205 10.1016/j.gie.2010.01.069 10.1111/nmo.14193 10.1111/nmo.13240 10.1111/nmo.12097 10.1016/j.cgh.2020.03.069 10.1111/nmo.13073 10.5056/jnm16111 10.7326/M15-0288 10.1111/nmo.14192 10.1002/sim.1186 10.5056/jnm15130 10.1111/dote.12344 10.5056/jnm17084 10.1152/ajpgi.00311.2006 10.1053/j.gastro.2010.09.037 10.1016/j.cgh.2018.07.042 10.1016/j.cgh.2016.10.022 10.1111/nmo.12218 |
ContentType | Journal Article |
Copyright | 2022 The Authors. published by John Wiley & Sons Ltd. 2022 The Authors. Neurogastroenterology & Motility published by John Wiley & Sons Ltd. 2022. This article is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
Copyright_xml | – notice: 2022 The Authors. published by John Wiley & Sons Ltd. – notice: 2022 The Authors. Neurogastroenterology & Motility published by John Wiley & Sons Ltd. – notice: 2022. This article is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
DBID | 24P AAYXX CITATION CGR CUY CVF ECM EIF NPM 7TK K9. 7X8 5PM |
DOI | 10.1111/nmo.14419 |
DatabaseName | Wiley Online Library Open Access CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Neurosciences Abstracts ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest Health & Medical Complete (Alumni) Neurosciences Abstracts MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE ProQuest Health & Medical Complete (Alumni) |
Database_xml | – sequence: 1 dbid: 24P name: Wiley Online Library Open Access url: https://authorservices.wiley.com/open-science/open-access/browse-journals.html sourceTypes: Publisher – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Anatomy & Physiology |
DocumentTitleAlternate | Bredenoord et al |
EISSN | 1365-2982 |
EndPage | n/a |
ExternalDocumentID | PMC9786273 35665566 10_1111_nmo_14419 NMO14419 |
Genre | reviewArticle Meta-Analysis Review Research Support, Non-U.S. Gov't Journal Article |
GrantInformation_xml | – fundername: Medtronic – fundername: ; |
GroupedDBID | --- .3N .GA .Y3 05W 0R~ 10A 123 1OB 1OC 24P 29N 31~ 33P 36B 3SF 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5HH 5LA 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHHS AAHQN AAIPD AAKAS AAMNL AANHP AANLZ AAONW AASGY AAXRX AAYCA AAZKR ABCQN ABCUV ABDBF ABEML ABOCM ABPVW ABQWH ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACGFS ACGOF ACMXC ACPOU ACPRK ACRPL ACSCC ACUHS ACXBN ACXQS ACYXJ ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADNMO ADOZA ADXAS ADZCM ADZMN AEEZP AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFEBI AFFPM AFGKR AFPWT AFWVQ AFZJQ AHBTC AHEFC AHMBA AIACR AITYG AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMBMR AMYDB ATUGU AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BY8 C45 CAG COF CS3 D-6 D-7 D-E D-F DCZOG DPXWK DR2 DRFUL DRMAN DRSTM DTERQ DU5 EAD EAP EAS EBC EBD EBS EBX EJD EMB EMK EMOBN EPT ESX EX3 F00 F01 F04 F5P FEDTE FUBAC FZ0 G-S G.N GODZA H.X HF~ HGLYW HVGLF HZI HZ~ IHE IX1 J0M K48 KBYEO LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ O66 O9- OIG OVD P2P P2W P2X P2Z P4B P4D PALCI PQQKQ Q.N Q11 QB0 Q~Q R.K RIWAO RJQFR ROL RX1 SAMSI SUPJJ SV3 TEORI TUS UB1 W8V W99 WBKPD WHWMO WIH WIJ WIK WIN WOHZO WOW WQJ WRC WVDHM WXI WXSBR XG1 YFH ZZTAW ~IA ~WT AAYXX AEYWJ AGHNM AGQPQ AGYGG CITATION AAMMB AEFGJ AGXDD AIDQK AIDYY CGR CUY CVF ECM EIF NPM 7TK K9. 7X8 5PM |
ID | FETCH-LOGICAL-c4439-35c7b82986170eedffa1ec210d5126bad1a813273270f693475ffcd97edab0983 |
IEDL.DBID | DR2 |
ISSN | 1350-1925 1365-2982 |
IngestDate | Thu Aug 21 18:40:28 EDT 2025 Fri Sep 05 09:08:25 EDT 2025 Fri Jul 25 03:46:31 EDT 2025 Mon Jul 21 06:02:14 EDT 2025 Thu Apr 24 23:00:06 EDT 2025 Tue Jul 01 00:43:37 EDT 2025 Wed Jan 22 16:22:58 EST 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 11 |
Keywords | dysphagia catheter manometry reflux disease achalasia esophagus |
Language | English |
License | Attribution 2022 The Authors. Neurogastroenterology & Motility published by John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c4439-35c7b82986170eedffa1ec210d5126bad1a813273270f693475ffcd97edab0983 |
Notes | Funding information The research project was sponsored by Medtronic, which contributed to the project design, data collection and analysis, and manuscript writing. The lead author had full access to all data and final responsibility for the decision to submit for publication. The author was not paid to write this article by the sponsor or any other agency. ObjectType-Article-2 SourceType-Scholarly Journals-1 content type line 14 ObjectType-Feature-3 ObjectType-Evidence Based Healthcare-1 ObjectType-Article-1 ObjectType-Feature-2 ObjectType-Review-3 content type line 23 |
OpenAccessLink | https://proxy.k.utb.cz/login?url=https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fnmo.14419 |
PMID | 35665566 |
PQID | 2724505771 |
PQPubID | 1006536 |
PageCount | 14 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_9786273 proquest_miscellaneous_2674004862 proquest_journals_2724505771 pubmed_primary_35665566 crossref_primary_10_1111_nmo_14419 crossref_citationtrail_10_1111_nmo_14419 wiley_primary_10_1111_nmo_14419_NMO14419 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | November 2022 |
PublicationDateYYYYMMDD | 2022-11-01 |
PublicationDate_xml | – month: 11 year: 2022 text: November 2022 |
PublicationDecade | 2020 |
PublicationPlace | England |
PublicationPlace_xml | – name: England – name: Oxford – name: Hoboken |
PublicationTitle | Neurogastroenterology and motility |
PublicationTitleAlternate | Neurogastroenterol Motil |
PublicationYear | 2022 |
Publisher | Wiley Subscription Services, Inc John Wiley and Sons Inc |
Publisher_xml | – name: Wiley Subscription Services, Inc – name: John Wiley and Sons Inc |
References | 2015; 163 2012; 143 2009; 41 2013; 25 2013; 27 2015; 149 2019; 17 2014; 49 2017; 29 2020; 32 2021; 30 2020; 19 2018; 24 2015; 27 2021; 33 2017; 15 2007; 292 1954; 10 2002; 21 2020; 115 2022; 34 2018; 30 2009; 6 2016; 29 2016; 28 2011; 140 2010; 72 2016; 22 e_1_2_10_23_1 e_1_2_10_24_1 e_1_2_10_21_1 e_1_2_10_22_1 e_1_2_10_20_1 e_1_2_10_2_1 e_1_2_10_4_1 e_1_2_10_18_1 e_1_2_10_3_1 e_1_2_10_19_1 e_1_2_10_6_1 e_1_2_10_16_1 e_1_2_10_5_1 e_1_2_10_17_1 Carlson DA (e_1_2_10_30_1) 2021; 30 e_1_2_10_8_1 e_1_2_10_14_1 e_1_2_10_7_1 e_1_2_10_15_1 e_1_2_10_12_1 e_1_2_10_9_1 e_1_2_10_13_1 e_1_2_10_34_1 e_1_2_10_10_1 e_1_2_10_33_1 e_1_2_10_11_1 e_1_2_10_32_1 e_1_2_10_31_1 e_1_2_10_29_1 e_1_2_10_27_1 e_1_2_10_28_1 e_1_2_10_25_1 e_1_2_10_26_1 |
References_xml | – volume: 22 start-page: 112 issue: 1 year: 2016 article-title: Effects of metoclopramide on esophageal motor activity and esophagogastric junction compliance in healthy volunteers publication-title: J Neurogastroenterol Motil. – volume: 34 issue: 1 year: 2022 article-title: Validation of secondary peristalsis classification using FLIP panometry in 741 subjects undergoing manometry publication-title: Neurogastroenterol Motil – volume: 140 start-page: 82 issue: 1 year: 2011 end-page: 90 article-title: Mechanical properties of the esophagus in eosinophilic esophagitis publication-title: Gastroenterology. – volume: 10 start-page: 101 issue: 1 year: 1954 end-page: 129 article-title: The combination of estimates from different experiments publication-title: Biometrics. – volume: 24 start-page: 255 issue: 2 year: 2018 article-title: Axial movements and length changes of the human lower esophageal sphincter during respiration and distension‐induced secondary peristalsis using functional luminal imaging probe publication-title: J Neurogastroenterol Motil – volume: 17 start-page: 674 issue: 4 year: 2019 end-page: 681 article-title: Normal values of esophageal distensibility and distension‐induced contractility measured by functional luminal imaging probe panometry publication-title: Clin Gastroenterol Hepatol – volume: 149 start-page: 1742 issue: 7 year: 2015 end-page: 1751 article-title: The functional lumen imaging probe detects esophageal contractility not observed with manometry in patients with achalasia publication-title: Gastroenterology. – volume: 163 start-page: 461 issue: 6 year: 2015 end-page: 464 article-title: Good publication practice for communicating company‐sponsored medical research: GPP3 publication-title: Ann Intern Med. – volume: 32 issue: 9 year: 2020 article-title: The use of impedance planimetry (Endoscopic Functional Lumen Imaging Probe, EndoFLIP®) in the gastrointestinal tract: a systematic review publication-title: Neurogastroenterol Motil – volume: 33 issue: 9 year: 2021 article-title: Esophagogastric junction outflow obstruction publication-title: Neurogastroenterol Motil – volume: 21 start-page: 1539 issue: 11 year: 2002 end-page: 1558 article-title: Quantifying heterogeneity in a meta‐analysis publication-title: Stat Med. – volume: 6 issue: 7 year: 2009 article-title: Preferred reporting items for systematic reviews and meta‐analyses: the PRISMA statement publication-title: PLoS Med – volume: 15 start-page: 325 issue: 3 year: 2017 end-page: 334 article-title: Functional lumen imaging probe for the management of esophageal disorders: expert review from the Clinical Practice Updates Committee of the AGA Institute publication-title: Clin Gastroenterol Hepatol – volume: 292 start-page: G377 issue: 1 year: 2007 end-page: G384 article-title: The functional lumen imaging probe (FLIP) for evaluation of the esophagogastric junction publication-title: Am J Physiol Gastrointest Liver Physiol – volume: 27 start-page: 1495 issue: 10 year: 2015 end-page: 1503 article-title: Esophagogastric junction distensibility in the management of achalasia patients: relation to treatment outcome publication-title: Neurogastroenterol Motil – volume: 143 start-page: 328 issue: 2 year: 2012 end-page: 335 article-title: Efficacy of treatment for patients with achalasia depends on the distensibility of the esophagogastric junction publication-title: Gastroenterology. – volume: 19 start-page: 1058 year: 2020 end-page: 1060 article-title: Esophagogastric junction opening parameters are consistently abnormal in untreated achalasia publication-title: Clin Gastroenterol Hepatol. – volume: 28 start-page: 1844 issue: 12 year: 2016 end-page: 1853 article-title: Evaluation of esophageal distensibility in eosinophilic esophagitis: an update and comparison of functional lumen imaging probe analytic methods publication-title: Neurogastroenterol Motil – volume: 30 issue: 3 year: 2018 article-title: The relationship between esophageal acid exposure and the esophageal response to volumetric distention publication-title: Neurogastroenterol Motil – volume: 72 start-page: 272 issue: 2 year: 2010 end-page: 278 article-title: Esophagogastric junction distensibility assessed with an endoscopic functional luminal imaging probe (EndoFLIP) publication-title: Gastrointest Endosc – volume: 115 start-page: 1786 issue: 11 year: 2020 end-page: 1796 article-title: Use of the functional lumen imaging probe in clinical esophagology publication-title: Am J Gastroenterol – volume: 41 start-page: 2 issue: 1 year: 2009 end-page: 8 article-title: Stepwise radiofrequency ablation of Barrett's esophagus preserves esophageal inner diameter, compliance, and motility publication-title: Endoscopy. – volume: 25 start-page: e765 issue: 11 year: 2013 end-page: e771 article-title: Regional variation in distal esophagus distensibility assessed using the functional luminal imaging probe (FLIP) publication-title: Neurogastroenterol Motil – volume: 27 start-page: 400 issue: 2 year: 2013 end-page: 405 article-title: Intraoperative assessment of esophagogastric junction distensibility during per oral endoscopic myotomy (POEM) for esophageal motility disorders publication-title: Surg Endosc – volume: 25 start-page: 904 issue: 11 year: 2013 end-page: 910 article-title: Measurement of esophago‐gastric junction cross‐sectional area and distensibility by an endolumenal functional lumen imaging probe for the diagnosis of gastro‐esophageal reflux disease publication-title: Neurogastroenterol Motil – volume: 25 start-page: 496 issue: 6 year: 2013 end-page: 501 article-title: Distensibility of the esophagogastric junction assessed with the functional lumen imaging probe (FLIP™) in achalasia patients publication-title: Neurogastroenterol Motil – volume: 33 issue: 1 year: 2021 article-title: Esophageal motility disorders on high‐resolution manometry: Chicago classification version 4.0(©) publication-title: Neurogastroenterol Motil – volume: 29 issue: 8 year: 2017 article-title: Esophagogastric junction in systemic sclerosis: a study with the functional lumen imaging probe publication-title: Neurogastroenterol Motil. – volume: 24 start-page: 241 issue: 2 year: 2018 article-title: Acotiamide has no effects on esophageal motor activity or esophagogastric junction compliance publication-title: J Neurogastroenterol Motil – volume: 49 start-page: 1307 issue: 9 year: 2014 end-page: 1313 article-title: Effects of mosapride on esophageal motor activity and esophagogastric junction compliance in healthy volunteers publication-title: J Gastroenterol. – volume: 29 start-page: 463 issue: 5 year: 2016 end-page: 471 article-title: Esophagogastric junction distensibility in hiatus hernia publication-title: Dis Esophagus – volume: 30 start-page: e1250 year: 2021 end-page: e1262 article-title: Validation of clinically relevant thresholds of esophagogastric junction obstruction using FLIP panometry publication-title: Clin Gastroenterol Hepatol – ident: e_1_2_10_27_1 doi: 10.1111/nmo.12651 – volume: 30 start-page: e1250 year: 2021 ident: e_1_2_10_30_1 article-title: Validation of clinically relevant thresholds of esophagogastric junction obstruction using FLIP panometry publication-title: Clin Gastroenterol Hepatol – ident: e_1_2_10_3_1 doi: 10.14309/ajg.0000000000000773 – ident: e_1_2_10_23_1 doi: 10.1007/s00535-013-0876-0 – ident: e_1_2_10_4_1 doi: 10.1111/nmo.12888 – ident: e_1_2_10_29_1 doi: 10.1111/nmo.13980 – ident: e_1_2_10_15_1 doi: 10.1053/j.gastro.2015.08.005 – ident: e_1_2_10_12_1 doi: 10.2307/3001666 – ident: e_1_2_10_26_1 doi: 10.1007/s00464-012-2484-0 – ident: e_1_2_10_31_1 doi: 10.1055/s-0028-1103451 – ident: e_1_2_10_6_1 doi: 10.1053/j.gastro.2012.04.048 – ident: e_1_2_10_10_1 doi: 10.1371/journal.pmed.1000097 – ident: e_1_2_10_8_1 doi: 10.1111/nmo.14058 – ident: e_1_2_10_19_1 doi: 10.1111/nmo.12205 – ident: e_1_2_10_21_1 doi: 10.1016/j.gie.2010.01.069 – ident: e_1_2_10_5_1 doi: 10.1111/nmo.14193 – ident: e_1_2_10_9_1 doi: 10.1111/nmo.13240 – ident: e_1_2_10_7_1 doi: 10.1111/nmo.12097 – ident: e_1_2_10_28_1 doi: 10.1016/j.cgh.2020.03.069 – ident: e_1_2_10_24_1 doi: 10.1111/nmo.13073 – ident: e_1_2_10_17_1 doi: 10.5056/jnm16111 – ident: e_1_2_10_34_1 doi: 10.7326/M15-0288 – ident: e_1_2_10_33_1 doi: 10.1111/nmo.14192 – ident: e_1_2_10_13_1 doi: 10.1002/sim.1186 – ident: e_1_2_10_16_1 doi: 10.5056/jnm15130 – ident: e_1_2_10_22_1 doi: 10.1111/dote.12344 – ident: e_1_2_10_25_1 doi: 10.5056/jnm17084 – ident: e_1_2_10_2_1 doi: 10.1152/ajpgi.00311.2006 – ident: e_1_2_10_20_1 doi: 10.1053/j.gastro.2010.09.037 – ident: e_1_2_10_14_1 doi: 10.1016/j.cgh.2018.07.042 – ident: e_1_2_10_32_1 doi: 10.1016/j.cgh.2016.10.022 – ident: e_1_2_10_18_1 doi: 10.1111/nmo.12218 – ident: e_1_2_10_11_1 |
SSID | ssj0006246 |
Score | 2.4419007 |
SecondaryResourceType | review_article |
Snippet | Background
The functional lumen imaging probe (Endoflip™) is increasingly used for evaluation of patients with esophageal symptoms. To improve the... The functional lumen imaging probe (Endoflip™) is increasingly used for evaluation of patients with esophageal symptoms. To improve the interpretation of... BackgroundThe functional lumen imaging probe (Endoflip™) is increasingly used for evaluation of patients with esophageal symptoms. To improve the... A meta‐analysis of clinical studies describing Endoflip™ use for measurements of esophagogastric junction distensibility index (EGJ‐DI) in healthy subjects... |
SourceID | pubmedcentral proquest pubmed crossref wiley |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | e14419 |
SubjectTerms | achalasia Adult catheter Clinical medicine Clinical Review Diagnostic Imaging dysphagia Esophageal Achalasia Esophagogastric Junction - diagnostic imaging Esophagus Healthy Volunteers Humans manometry Manometry - methods Meta-analysis reflux disease |
Title | Normative values for esophageal functional lumen imaging probe measurements: A meta‐analysis |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fnmo.14419 https://www.ncbi.nlm.nih.gov/pubmed/35665566 https://www.proquest.com/docview/2724505771 https://www.proquest.com/docview/2674004862 https://pubmed.ncbi.nlm.nih.gov/PMC9786273 |
Volume | 34 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
journalDatabaseRights | – providerCode: PRVEBS databaseName: EBSCOhost Academic Search Ultimate customDbUrl: https://search.ebscohost.com/login.aspx?authtype=ip,shib&custid=s3936755&profile=ehost&defaultdb=asn eissn: 1365-2982 dateEnd: 20241001 omitProxy: true ssIdentifier: ssj0006246 issn: 1350-1925 databaseCode: ABDBF dateStart: 19981101 isFulltext: true titleUrlDefault: https://search.ebscohost.com/direct.asp?db=asn providerName: EBSCOhost – providerCode: PRVWIB databaseName: Wiley Online Library - Core collection (SURFmarket) issn: 1350-1925 databaseCode: DR2 dateStart: 19970101 customDbUrl: isFulltext: true eissn: 1365-2982 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0006246 providerName: Wiley-Blackwell |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1fT9swED8VHqa9sA0GZLDKQ2jaS1DixHa9PVUIhJAoCIHEw0RkO46oWNNpbSexJz4Cn3GfZGfnD3QMCU1KpVS5po5zd_6dff4dwLZSmgnFdKgSk4RpXphQSp2HSlBmhLQR2pTLthjwg_P08IJddOBLsxem4odoJ9ycZXh_7Qxc6ckDIy9HY7cy6Sk_44T5JdrTe-ooTqudRQmLQkQxrGYVclk87S_nx6JHAPNxnuRD_OoHoP1X8LVpepV3cr0zm-od8-svVsf_fLbXsFQDU9KvNOkNdGy5DCv9EoPy0Q35SHyqqJ-DX4YXR_WK_ApcDirQ-9MSxxtuJwRRMLGuOAJ6KryhGzir-Ubi_GBJhiNfGIm4UjaWjO7nKCefSR-_T9Xv2ztVc6W8hfP9vbPdg7Cu2RCaFLFNmOAb1j0qe47oHcffolCxNRhX5ogsuFZ5rHoYAAs8ooLLJBWsKEwuhc2VjmQvWYXFclzadSDGWIPeSLNIqzQWXEqm8sRgCKZ5TpUN4FPz9jJTE5q7uhrfsiawwW7MfDcGsNWKfq9YPP4ltNmoQFYb8iSjgqYuhhNxAB_ay2iCbl1FlXY8QxkuvCfkNIC1SmPaf0HF5Aw_AYg5XWoFHL33_JVyeOVpvjG-59hR-JheVZ5ueDY4OvYn754vugEvqdvI4XdVbsLi9MfMvkd4NdVdWKDpSddb0x-aFCYw |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1fb9MwED9Nm8R4QbA_kFHAoAntJVLqxHaNeKkQU4G17KGT9kRkO45WiaZobZF420fYZ9wn4c5JQ6uBhNRKrXJNk5zv7ndn-3cAx8ZYoYywsUldGmdF6WKtbREbxYVT2idoU7TaYiQHF9nnS3G5Be9Xe2Fqfoi24EaWEfw1GTgVpNesvJrOaGqSOD93MskTGtM8O2_9sOT13qJUJDHiGNHwCtE6nvanm9HoHsS8v1JyHcGGEHT6GB412JH1a2U_gS1f7cF-v8K8efqLvWVhNWcok-_Bg2Ezab4P30Y1Lv3pGVF7-zlDoMo89S9AZ4InpNhWlwQZuaqKTaahdxGjbjOeTf-UEefvWB-_L8zdza1p6EwO4OL04_jDIG7aKsQuQ_gRp6gE2-O6R1zsGCLL0nS9w9SvwOAvrSm6poc5qsJXUkqdZkqUpSu08oWxie6lh7BdzSr_DJhz3qHDsCKxJusqqbUwReowS7Ky4MZHcLJ6vLlrOMep9cX3fJV7oCbyoIkI3rSiP2qijb8JdVY6yhtbm-dc8YzSLNWN4HV7GK2Epj5M5WdLlJEqOCvJI3haq7T9lxQRrcB3BGpD2a0AMXBvHqkmV4GJG1NwiQ8KbzMMi39feD4afg0fjv5f9BXsDsbDs_zs0-jLc3jIad9F2ATZge3F9dK_QDS0sC_DoP8NnXMIsw |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1ta9RAEB5KC8UvWlttY6uuIuKXlFyS3b3VT4d61JeeIhb6oTTsW7Do5Yp3V9BP_gR_o7_Emc1Le1ahCDnIkbncZjMz-8zu7DMAj7Q2XGpuYp3ZLM5daWOljIu1TLmVyidoU5RtMRJ7B_nrQ364BM_avTA1P0Q34UaWEfw1GfipKy8YeTWe0MokUX6u5AKjK0JEH865o0Raby3KeBIjjOENrRCl8XQ_XRyMLiHMy4mSFwFsGIGGN-CobXudePJ5dz4zu_b7H7SO__lwa3C9QaZsUKvSTVjy1TpsDCqMysff2GMWckXDJPw6rO43S_IbcDyqUe-ZZ0Qc7qcMYTDzVB0BXRXekEbOesKRkSOs2Mk4VEZiVMvGs_H5JOX0KRvg95n-9eOnbshSbsHB8OXH53txU7QhtjmCmzjDV2z6qeoT0zsOwGWpe95iYOkQWgijXU_3MQKWeCSlUFkueVlap6R32iSqn92G5WpS-S1g1nqL7sjwxOi8J4VSXLvMYgxmhEu1j-BJ-_YK2zCaU2GNL0Ub2WA3FqEbI3jYiZ7WNB5_E9ppVaBoLHlapDLNKYiTvQgedJfRBmlhRVd-MkcZIYMrFGkEm7XGdP-SIV7m-IlALuhSJ0D83otXqpNPgecbA3yBHYWPGVTl3w0vRvvvwsmdq4veh9X3L4bF21ejN9twLaVNHWGH5Q4sz77O_V2EWjNzL5jUb1kkKCQ |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Normative+values+for+esophageal+functional+lumen+imaging+probe+measurements%3A+A+meta-analysis&rft.jtitle=Neurogastroenterology+and+motility&rft.au=Bredenoord%2C+Albert+J&rft.au=Rancati%2C+Francesca&rft.au=Lin%2C+Haiying&rft.au=Schwartz%2C+Naama&rft.date=2022-11-01&rft.issn=1365-2982&rft.eissn=1365-2982&rft.volume=34&rft.issue=11&rft.spage=e14419&rft_id=info:doi/10.1111%2Fnmo.14419&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1350-1925&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1350-1925&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1350-1925&client=summon |